Log In
Print this Print this

Inflectra, Remsima, infliximab (CT-P13)

  Manage Alerts
Collapse Summary General Information
Company Celltrion Inc.
DescriptionHumanized mAb against tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today